A Clinico-Etiological Evaluation of Hirsutism Patients: A Case Series

    September 2021 in “ Journal of pharmaceutical research international ”
    Surendra Kumar Patel, J. B. Dave, Timir Y. Mehta
    TLDR The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.
    This study evaluated five female patients aged 16 to 22 years diagnosed with hirsutism, focusing on clinical presentation, ultrasound imaging, and hormonal evaluation. The ultrasound revealed that one patient had a bulky ovary, while four had multiple ovarian follicles. Hormonal assessments showed elevated levels of 17-OHP, serum testosterone, and serum insulin in some patients, with one patient having a high LH: FSH ratio. The study found a strong correlation between hirsutism and elevated levels of these hormones, but no significant correlation with DHEAS, serum prolactin, serum cortisol, and serum TSH levels. The findings suggest a link between polycystic ovary syndrome (PCOS) and hirsutism.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 25 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 3 weeks ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 10 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    3 / 3 results